Niagen Bioscience (NAGE) Capital Leases (2011 - 2024)

Niagen Bioscience (NAGE) posted quarterly Capital Leases of $2000.0 for Q3 2024, down 85.71% year-over-year from $14000.0 in Q4 2023, and down 66.67% quarter-over-quarter from $6000.0 in Q2 2024.

Niagen Bioscience (NAGE) Capital Leases (2011 - 2024) Analysis & Trends

Niagen Bioscience (NAGE) has reported Capital Leases for 12 consecutive years, with $2000.0 the latest figure, recorded in Q3 2024.

  • In Q3 2024, Capital Leases fell 85.71% year-over-year to $2000.0; the TTM figure through Sep 2024 stood at $2000.0 (down 85.71% YoY), while the FY2023 annual figure was $12000.0, down 45.45% from the prior year.
  • Capital Leases fell to $2000.0 in Q3 2024 per NAGE's latest filing, from $6000.0 in the prior quarter.
  • Across five years, Capital Leases topped out at $36000.0 in Q1 2020 and bottomed at $2000.0 in Q3 2024.
  • Historically, Capital Leases has averaged $16076.9 across 5 years, with a median of $14000.0 in 2023.
  • Annual changes were most pronounced in 2020 — Capital Leases climbed 11.11% — and 2024, when it plunged 85.71%.
  • Niagen Bioscience's Capital Leases stood at $20000.0 in 2020, then slumped by 45.0% to $11000.0 in 2021, then surged by 100.0% to $22000.0 in 2022, then sank by 45.45% to $12000.0 in 2023, then plunged by 83.33% to $2000.0 in 2024.
  • Business Quant data shows NAGE's Capital Leases at $2000.0 in Q3 2024, $6000.0 in Q2 2024, and $9000.0 in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Niagen Bioscience 238.30 Mn 171.56 Mn 19.31 Mn

Historic Data

Download Data
DateValue
Sep 30, 2024 2,000.00
Jun 30, 2024 6,000.00
Mar 31, 2024 9,000.00
Dec 31, 2023 12,000.00
Sep 30, 2023 14,000.00
Jun 30, 2023 17,000.00
Mar 31, 2023 20,000.00
Dec 31, 2022 22,000.00
Sep 30, 2021 11,000.00
Jun 30, 2021 13,000.00
Dec 31, 2020 20,000.00
Jun 30, 2020 27,000.00
Mar 31, 2020 36,000.00
Dec 31, 2019 18,000.00
Sep 30, 2019 70,000.00
Jun 30, 2019 121,000.00
Mar 31, 2019 94,000.00
Dec 31, 2018 137,000.00
Sep 30, 2018 178,000.00
Jun 30, 2018 219,000.00